Oric Pharmaceuticals (ORIC) Cash from Operations (2019 - 2026)

Oric Pharmaceuticals' Cash from Operations history runs 8 years deep, the most recent figure standing at 32438000.0 for Q1 2026.

• Quarterly Cash from Operations changed 0.29% year-over-year to 32438000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 110875000.0 (up 3.59% YoY) and the FY2025 annual result came in at 110970000.0, up 1.5% from the prior year.
• Cash from Operations was 32438000.0 for Q1 2026 at Oric Pharmaceuticals, down from 22483000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 15329000.0 in Q4 2022 and bottomed at 32533000.0 in Q1 2025.
• A 5-year average of 24523588.24 and a median of 24270000.0 in 2023 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations tumbled 59.12% — and 2025, when it grew 19.86%.
• Oric Pharmaceuticals' Cash from Operations stood at 15329000.0 in 2022, then sank by 58.33% to 24270000.0 in 2023, then decreased by 15.59% to 28054000.0 in 2024, then advanced by 19.86% to 22483000.0 in 2025, then slumped by 44.28% to 32438000.0 in 2026.
• Business Quant data shows ORIC's Cash from Operations at 32438000.0 in Q1 2026, 22483000.0 in Q4 2025, and 25112000.0 in Q3 2025.